| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.003 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.004 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.095 | 0.004 |